10-Q Filing

BNB PLUS CORP. CIK: 744452 Q3 2021

Filing Information

Form Type	10-Q
Accession Number	`0001104659-21-104140`
Period End Date	20210630
Filing Date	20210812
Fiscal Year	2021
Fiscal Period	Q3
XBRL Instance	apdn-20210630x10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 79 Income Statement 77 Cash Flow Statement 77 Stockholders Equity 52

Balance Sheet 79 line items

Line Item	Tag	Value	Unit	Period
Allowance on accounts receivable (in dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$7.44K	USD	Point-in-time
Allowance on accounts receivable (in dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$11.97K	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$7.79M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$12.17M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable, net of allowance of $7,438 and $11,968 at June 30, 2021 and September 30, 2020, respectively	`AccountsReceivableNetCurrent`	$194.32K	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable, net of allowance of $7,438 and $11,968 at June 30, 2021 and September 30, 2020, respectively	`AccountsReceivableNetCurrent`	$737.35K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Inventories	`InventoryNet`	$429.12K	USD	Point-in-time
Inventories	`InventoryNet`	$497.37K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$599.30K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$356.41K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$9.08M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$13.70M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.58M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$1.28M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	5.14M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	7.49M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	5.14M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	4.06M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	1.21M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	7.49M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	4.97M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	3.49M	shares	Point-in-time
Deposits	`DepositsAssetsNoncurrent`	$95.05K	USD	Point-in-time
Deposits	`DepositsAssetsNoncurrent`	$95.08K	USD	Point-in-time
Goodwill	`Goodwill`	$285.39K	USD	Point-in-time
Goodwill	`Goodwill`	$285.39K	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$536.35K	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$605.33K	USD	Point-in-time
Total Assets	`Assets`	$11.34M	USD	Point-in-time
Total Assets	`Assets`	$17.19M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$1.93M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$1.32M	USD	Point-in-time
Promissory notes payable-current portion	`NotesPayableToBankCurrent`	$329.30K	USD	Point-in-time
Secured convertible notes payable, net of debt issuance costs	`ConvertibleNotesPayableCurrent`	$1.50M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$511.04K	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$252.81K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.57M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.27M	USD	Point-in-time
Long term accrued liabilities	`AccountsPayableAndAccruedLiabilitiesNoncurrent`	$31.47K	USD	Point-in-time
Long term accrued liabilities	`AccountsPayableAndAccruedLiabilitiesNoncurrent`	$848.31K	USD	Point-in-time
Promissory notes payable-long term portion	`NotesPayableToBankNoncurrent`	$517.49K	USD	Point-in-time
Total liabilities	`Liabilities`	$5.63M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.61M	USD	Point-in-time
Commitments and contingencies (Note H)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note H)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of March 31, 2021 and September 30, 2020, respectively	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of March 31, 2021 and September 30, 2020, respectively	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.001 per share; 200,000,000 shares authorized as of March 31, 2021 and September 30, 2020, 7,486,120 and 5,142,779 shares issued and outstanding as of March 31, 2021 and September 30, 2020, respectively	`CommonStockValue`	$5.14K	USD	Point-in-time
Common stock, par value $0.001 per share; 200,000,000 shares authorized as of March 31, 2021 and September 30, 2020, 7,486,120 and 5,142,779 shares issued and outstanding as of March 31, 2021 and September 30, 2020, respectively	`CommonStockValue`	$7.49K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$275.55M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$295.19M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-279.61M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-269.84M	USD	Point-in-time
Applied DNA Sciences, Inc. stockholders' equity:	`StockholdersEquity`	$15.59M	USD	Point-in-time
Applied DNA Sciences, Inc. stockholders' equity:	`StockholdersEquity`	$5.72M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-4.23K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-8.72K	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.58M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.78M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$18.62M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.27M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.71M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.72M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.22M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-848.50K	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$17.19M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$11.34M	USD	Point-in-time

Income Statement 77 line items

Line Item	Tag	Value	Unit	Period
Total revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$1.62M	USD	3 Qtrs
Total revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$431.52K	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$1.70M	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$5.99M	USD	3 Qtrs
Cost of revenues	`CostOfRevenue`	$566.42K	USD	3 Qtrs
Cost of revenues	`CostOfRevenue`	$154.80K	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$1.15M	USD	3 Qtrs
Cost of revenues	`CostOfRevenue`	$550.46K	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$3.24M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$7.25M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$10.30M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$2.59M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$814.60K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.65M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$2.08M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.03M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$203.47K	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$61.87K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$247.77K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$544.56K	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$13.49M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$9.53M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$4.52M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$3.47M	USD	1 Quarter
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-8.48M	USD	3 Qtrs
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-8.66M	USD	3 Qtrs
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-3.37M	USD	1 Quarter
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-3.19M	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNet`	$-28.62K	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNet`	$11.97K	USD	3 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNet`	$-86.81K	USD	3 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNet`	$3.57K	USD	1 Quarter
Loss on extinguishment of convertible notes payable	`GainsLossesOnExtinguishmentOfDebt`	-	USD	3 Qtrs
Loss on extinguishment of convertible notes payable	`GainsLossesOnExtinguishmentOfDebt`	$-1.77M	USD	3 Qtrs
Gain on extinguishment of notes payable	`GainLossOnExtinguishmentOfNotesPayablesCaresAct`	-	USD	3 Qtrs
Gain on extinguishment of notes payable	`GainLossOnExtinguishmentOfNotesPayablesCaresAct`	$839.95K	USD	3 Qtrs
Other expense, net	`OtherNonoperatingIncomeExpense`	$-72.69K	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-191.53K	USD	3 Qtrs
Other expense, net	`OtherNonoperatingIncomeExpense`	$-334.53K	USD	3 Qtrs
Other expense, net	`OtherNonoperatingIncomeExpense`	$-82.80K	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-8.90M	USD	3 Qtrs
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-3.29M	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-9.77M	USD	3 Qtrs
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-3.45M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-1.52M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-8.90M	USD	3 Qtrs
NET LOSS	`ProfitLoss`	$-9.77M	USD	3 Qtrs
NET LOSS	`ProfitLoss`	$-4.81M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-3.45M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-2.66M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-2.95M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-3.29M	USD	1 Quarter
Less: Net (income) loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$4.49K	USD	3 Qtrs
Less: Net (income) loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-662.00	USD	1 Quarter
Less: Net (income) loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$528.00	USD	3 Qtrs
Less: Net (income) loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$2.28K	USD	1 Quarter
NET LOSS attributable to Applied DNA Sciences, Inc.	`NetIncomeLoss`	$-8.90M	USD	3 Qtrs
NET LOSS attributable to Applied DNA Sciences, Inc.	`NetIncomeLoss`	$-9.78M	USD	3 Qtrs
NET LOSS attributable to Applied DNA Sciences, Inc.	`NetIncomeLoss`	$-3.45M	USD	1 Quarter
NET LOSS attributable to Applied DNA Sciences, Inc.	`NetIncomeLoss`	$-3.29M	USD	1 Quarter
Deemed dividend related to warrant modifications	`DeemedDividendRelatedToWarrantModifications`	$-2.84K	USD	3 Qtrs
NET LOSS attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-3.29M	USD	1 Quarter
NET LOSS attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-9.78M	USD	3 Qtrs
NET LOSS attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-3.45M	USD	1 Quarter
NET LOSS attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-8.91M	USD	3 Qtrs
Net loss per share attributable to common stockholders-basic and diluted	`EarningsPerShareBasicAndDiluted`	$-1.45	USD	3 Qtrs
Net loss per share attributable to common stockholders-basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.72	USD	1 Quarter
Net loss per share attributable to common stockholders-basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.46	USD	1 Quarter
Net loss per share attributable to common stockholders-basic and diluted	`EarningsPerShareBasicAndDiluted`	$-2.54	USD	3 Qtrs
Weighted average shares outstanding- basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	6.72M	shares	3 Qtrs
Weighted average shares outstanding- basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	3.51M	shares	3 Qtrs
Weighted average shares outstanding- basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	4.58M	shares	1 Quarter
Weighted average shares outstanding- basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	7.49M	shares	1 Quarter

Cash Flow Statement 77 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-1.52M	USD	1 Quarter
Net loss	`ProfitLoss`	$-8.90M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-9.77M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-4.81M	USD	1 Quarter
Net loss	`ProfitLoss`	$-3.45M	USD	1 Quarter
Net loss	`ProfitLoss`	$-2.66M	USD	1 Quarter
Net loss	`ProfitLoss`	$-2.95M	USD	1 Quarter
Net loss	`ProfitLoss`	$-3.29M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$544.56K	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$203.47K	USD	3 Qtrs
Loss on extinguishment of convertible notes payable	`GainsLossesOnExtinguishmentOfDebt`	-	USD	3 Qtrs
Loss on extinguishment of convertible notes payable	`GainsLossesOnExtinguishmentOfDebt`	$-1.77M	USD	3 Qtrs
Gain on extinguishment of notes payable	`GainLossOnExtinguishmentOfNotesPayablesCaresAct`	-	USD	3 Qtrs
Gain on extinguishment of notes payable	`GainLossOnExtinguishmentOfNotesPayablesCaresAct`	$839.95K	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$1.63M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$797.58K	USD	3 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$19.20K	USD	3 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	-	USD	3 Qtrs
Provision for bad debts	`ProvisionForDoubtfulAccounts`	$6.25K	USD	3 Qtrs
Provision for bad debts	`ProvisionForDoubtfulAccounts`	$21.88K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-586.88K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$549.27K	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$-68.25K	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$302.01K	USD	3 Qtrs
Prepaid expenses and other current assets and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-17.37K	USD	3 Qtrs
Prepaid expenses and other current assets and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-242.88K	USD	3 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-402.78K	USD	3 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-1.53M	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenues`	$-197.78K	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenues`	$-258.23K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-8.16M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-8.68M	USD	3 Qtrs
Purchase of intangible asset	`PaymentsToAcquireIntangibleAssets`	-	USD	3 Qtrs
Purchase of intangible asset	`PaymentsToAcquireIntangibleAssets`	$36.52K	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$19.66K	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.64M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.64M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-56.18K	USD	3 Qtrs
Net proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$7.20M	USD	3 Qtrs
Net proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$1.10M	USD	Point-in-time
Net proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$2.61M	USD	3 Qtrs
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	3 Qtrs
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$13.76M	USD	3 Qtrs
Net proceeds from sale of common stock and warrants	`NetProceedsFromSaleOfCommonStockAndWarrants`	-	USD	3 Qtrs
Net proceeds from sale of common stock and warrants	`NetProceedsFromSaleOfCommonStockAndWarrants`	$10.64M	USD	3 Qtrs
Repayment of convertible notes	`RepaymentsOfConvertibleDebt`	$1.67M	USD	3 Qtrs
Repayment of convertible notes	`RepaymentsOfConvertibleDebt`	$107.80K	USD	3 Qtrs
Proceeds from promissory notes	`ProceedsFromConvertibleDebt`	-	USD	3 Qtrs
Proceeds from promissory notes	`ProceedsFromConvertibleDebt`	$846.79K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$18.58M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$14.70M	USD	3 Qtrs
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$4.39M	USD	3 Qtrs
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$10.37M	USD	3 Qtrs
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$12.17M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.79M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$558.99K	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.92M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$12.17M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.79M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$558.99K	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.92M	USD	Point-in-time
Cash paid during period for interest	`InterestPaidNet`	-	USD	3 Qtrs
Cash paid during period for interest	`InterestPaidNet`	$45.35K	USD	3 Qtrs
Cash paid during period for income taxes	`IncomeTaxesPaid`	-	USD	3 Qtrs
Cash paid during period for income taxes	`IncomeTaxesPaid`	-	USD	3 Qtrs
Interest paid in kind	`PaidInKindInterest`	$28.33K	USD	3 Qtrs
Interest paid in kind	`PaidInKindInterest`	$35.62K	USD	3 Qtrs
Property and equipment acquired, and included in accounts payable	`PropertyPlantAndEquipmentAcquiredAndIncludedInAccountsPayable`	$132.27K	USD	3 Qtrs
Property and equipment acquired, and included in accounts payable	`PropertyPlantAndEquipmentAcquiredAndIncludedInAccountsPayable`	$611.05K	USD	3 Qtrs
Deemed dividend-warrant repricing	`DeemedDividendWarrantRepricing`	-	USD	3 Qtrs
Deemed dividend-warrant repricing	`DeemedDividendWarrantRepricing`	$2.84K	USD	3 Qtrs
Deferred offering costs reclassified to additional paid in capital	`ReclassificationOfDeferredOfferingCostToAdditionalPaidInCapital`	-	USD	3 Qtrs
Deferred offering costs reclassified to additional paid in capital	`ReclassificationOfDeferredOfferingCostToAdditionalPaidInCapital`	$109.70K	USD	3 Qtrs
FV of warrants issued	`FairValueOfWarrantsIssued`	-	USD	3 Qtrs
FV of warrants issued	`FairValueOfWarrantsIssued`	$1.07M	USD	3 Qtrs
Intangible asset costs incurred, and included in accounts payable	`IntangibleAssetCostsIncurredAndIncludedInAccountsPayable`	-	USD	3 Qtrs
Intangible asset costs incurred, and included in accounts payable	`IntangibleAssetCostsIncurredAndIncludedInAccountsPayable`	$14.38K	USD	3 Qtrs

Stockholders Equity 52 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.58M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.78M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$18.62M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.27M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.71M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.72M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.22M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-848.50K	USD	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	5.14M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	4.06M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	1.21M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	7.49M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	4.97M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	3.49M	shares	Point-in-time
Common stock issued in public offering, net of offering costs	`SharesIssuedInPublicOffering`	$-10.53M	USD	1 Quarter
Common stock issued in public offering, net of offering costs	`SharesIssuedInPublicOffering`	$-13.76M	USD	1 Quarter
Common stock issued in public offering, net of offering costs (in shares)	`SharesIssuedInPublicOfferingShares`	2.29M	shares	1 Quarter
Exercise of warrants	`StockIssuedDuringPeriodValueWarrantsExercised`	$2.77M	USD	1 Quarter
Exercise of warrants	`StockIssuedDuringPeriodValueWarrantsExercised`	$4.44M	USD	1 Quarter
Exercise of warrants	`StockIssuedDuringPeriodValueWarrantsExercised`	$2.61M	USD	1 Quarter
Exercise of warrants	`StockIssuedDuringPeriodValueWarrantsExercised`	$8.40K	USD	1 Quarter
Exercise of warrants (in shares)	`StockIssuedDuringPeriodValueWarrantsExercisedShare`	908,254.00	shares	1 Quarter
Exercise of warrants (in shares)	`StockIssuedDuringPeriodValueWarrantsExercisedShare`	566,950.00	shares	1 Quarter
Fair value of warrants issued in connection with convertible note repayment	`WarrantsIssuedDuringPeriodValueWarrants`	$1.64M	USD	1 Quarter
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$410.43K	USD	1 Quarter
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$571.50K	USD	1 Quarter
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$364.82K	USD	1 Quarter
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$227.27K	USD	1 Quarter
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$649.25K	USD	1 Quarter
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$205.49K	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.52M	USD	1 Quarter
Net loss	`ProfitLoss`	$-8.90M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-9.77M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-4.81M	USD	1 Quarter
Net loss	`ProfitLoss`	$-3.45M	USD	1 Quarter
Net loss	`ProfitLoss`	$-2.66M	USD	1 Quarter
Net loss	`ProfitLoss`	$-2.95M	USD	1 Quarter
Net loss	`ProfitLoss`	$-3.29M	USD	1 Quarter
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.58M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.78M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$18.62M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.27M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.71M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.72M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.22M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-848.50K	USD	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	5.14M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	4.06M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	1.21M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	7.49M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	4.97M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	3.49M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.